Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Explore available award and grant opportunities for fellows-in-training.
Make a choice that matters
The best care starts with the best information. See videos to help answer your questions.
The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline.
ACR Convergence, the ACR's annual meeting, is a private event. Programs presented at the meeting are for the education of attendees and purchasers of recorded presentations as authorized by the American College of Rheumatology. The information and materials displayed and presented during this meeting are the property of the ACR and the presenter and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced, or distributed without written permission of the American College of Rheumatology and the presenter. Any use of the program content for commercial purposes (which includes, but is not limited to, oral presentations, audiovisual materials used by speakers, and program handouts) without the written consent of the ACR is prohibited. This policy applies before, during, and after the meeting. The ACR will enforce its intellectual property rights and penalize those who infringe upon them.
ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, November 5-9.
Now, more than ever, the rheumatology community needs to maintain connection. ACR Convergence 2020 provides an opportunity to do just that. This fully virtual meeting is where rheumatology can collaborate, celebrate, innovate, and learn!
Get ready for an all-encompassing, all-virtual experience designed for the global rheumatology community. Get ready for ACR Convergence 2020.
We’ve given the ACR’s annual meeting a new name and a fresh look, and reimagined #ACR20 without losing the elements you care about most: stellar rheumatology education and outstanding networking opportunities.
We will be sharing permissions and reprints details in the coming weeks and months, and we promise to keep you fully informed.
The names, insignias, logos and acronyms of the ACR, the ARP, and the Rheumatology Research Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the express written permission of the American College of Rheumatology.
Copyright law covers all annual meeting abstracts published by the American College of Rheumatology. All rights reserved. No abstracts may be reproduced in any form or by any means without the prior permission of the publisher, except as permitted under section 107 and 108 of the 1976 United States Copyright Act.
For the purposes of this statement, the term “ACR Abstracts” refers to all annual meeting abstracts as published in Arthritis & Rheumatology and posted online, including the abstracts accepted for presentation during ARP sessions and the late-breaking category.
For the purposes of this statement, the term “ACR Posters” refers to the accepted abstract POSTER PRESENTATIONS as presented in the poster hall during the annual meeting. This does not include abstract text published in the online supplement of Arthritis & Rheumatology. All ACR Posters are the property of the ACR or the presenting author and cannot be reproduced or distributed without written permission from the ACR and the presenting author.
For the purposes of this statement, the term “reproduce” includes all forms of reproduction including, but not limited to, print, electronic, and photographed formats.
For the purposes of this statement, the term “presenting author” refers to the author who is designated as the individual who will present the work during the ACR's annual meeting, as identified through the abstract submission process.
c/o John Wiley & Sons, Inc.
111 River Street
Hoboken, NJ 07030
– Abstract ID Number
– Abstract Title
– Presenting Author’s Name
– A copy of Presenting Author’s written approval (Please Note: An email approval from Presenting Author is acceptable)
Following approval (see approval process above), an exhibiting organization may:
Following approval from Wiley (see approval process above), the ACR permits ACR Abstracts (i.e., all abstract content published in the online supplement) to be reprinted and disseminated following the annual meeting.
Abstract(s) reprinted from ACR Convergence held [insert meeting dates]. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).
Following approval from the presenting author and ACR (see approval process above), copies of actual ACR poster presentations (i.e., images of the poster presentation hung in the poster hall) may be reproduced.
Reprinted from ACR Convergence held [insert meeting dates]. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by [insert name of supporting company].
It is suggested when referencing disclosures in the reprints, that the ACR’s disclosure key be added to provide adequate context for abstracts:
None: Has no financial relationships to disclose